Armata Pharmaceuticals (ARMP) EPS (Basic) (2016 - 2026)
Quarterly results put EPS (Basic) at -$3.16 for Q1 2026, down 1655.56% from a year ago — trailing twelve months through Mar 2026 was -$7.78 (down 434.77% YoY), and the annual figure for FY2025 was -$4.8, down 823.08%.
Armata Pharmaceuticals has reported EPS (Basic) over the past 14 years, most recently at -$3.16 for Q1 2026.
- EPS (Basic) reached -$3.16 in Q1 2026 per ARMP's latest filing, up from -$3.43 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.25 in Q2 2024 and bottomed at -$3.43 in Q4 2025.
- Median EPS (Basic) over the past 5 years was -$0.3 (2022), compared with a mean of -$0.67.
- The largest annual shift saw EPS (Basic) surged 350.0% in 2024 before it tumbled 4387.5% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.29 in 2022, then plummeted by 89.66% to -$0.55 in 2023, then surged by 114.55% to $0.08 in 2024, then crashed by 4387.5% to -$3.43 in 2025, then increased by 7.87% to -$3.16 in 2026.
- Business Quant data shows EPS (Basic) for ARMP at -$3.16 in Q1 2026, -$3.43 in Q4 2025, and -$0.74 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 4.06 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 6.99 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 0.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.55 |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -3.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.16 |
| Dec 31, 2025 | -3.43 |
| Sep 30, 2025 | -0.74 |
| Jun 30, 2025 | -0.45 |
| Mar 31, 2025 | -0.18 |
| Dec 31, 2024 | 0.08 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | -0.69 |
| Dec 31, 2023 | -0.55 |
| Sep 30, 2023 | -0.86 |
| Jun 30, 2023 | -0.10 |
| Mar 31, 2023 | -0.40 |
| Dec 31, 2022 | -0.29 |
| Sep 30, 2022 | -0.24 |
| Jun 30, 2022 | -0.26 |
| Mar 31, 2022 | -0.30 |
| Dec 31, 2021 | -0.23 |
| Sep 30, 2021 | -0.22 |
| Jun 30, 2021 | -0.25 |
| Mar 31, 2021 | -0.27 |
| Dec 31, 2020 | -0.36 |
| Sep 30, 2020 | -0.31 |
| Jun 30, 2020 | -0.26 |
| Mar 31, 2020 | -0.49 |
| Dec 31, 2019 | -0.44 |
| Sep 30, 2019 | -0.73 |
| Jun 30, 2019 | -0.56 |
| Mar 31, 2019 | -0.80 |
| Dec 31, 2018 | -0.24 |
| Sep 30, 2018 | -0.60 |
| Jun 30, 2018 | -0.68 |
| Mar 31, 2018 | -0.24 |
| Dec 31, 2017 | -0.04 |
| Sep 30, 2017 | -0.09 |
| Jun 30, 2017 | -1.21 |
| Mar 31, 2017 | -1.94 |
| Dec 31, 2016 | -0.70 |
| Sep 30, 2016 | -3.23 |
| Jun 30, 2016 | -7.26 |